Editorial
Vascular Bioprinting

https://doi.org/10.1016/j.amjcard.2010.08.056Get rights and content

References (21)

There are more references available in the full text version of this article.

Cited by (6)

  • 3D bioprinting for drug discovery and development in pharmaceutics

    2017, Acta Biomaterialia
    Citation Excerpt :

    Compared to other technologies (such as soft lithography, surface patterning, and microfluidic-based manipulation), this powerful technology is a promising method for advancing physiologically-relevant tissue models and microarrays for biomedicine and pharmaceutical applications. Bioprinting technology has been used for the fabrication of a wide variety of 3D tissues including blood vessel [71,72], bone [73], tooth [74], lung [75], kidney [76], liver [77], cardiac [78], cartilage [79], skin [80], heart valve [81], brain [82], nervous [83], pancreas [84], retina [85], tendon [86], trachea vascular [87], composite tissues [88], and cervical tumor models [89]. Bioprinted tissue models for pharmaceutical use are not subject to the rigorous safety, ethical, and regulatory issues that are required for 3D bioprinted organ substitutes for transplantation.

  • Bioprinting: Principles and applications

    2015, Bioprinting: Principles and Applications
  • Organ printing and cell encapsulation

    2014, Scaffolds for Tissue Engineering: Biological Design, Materials, and Fabrication

This work was funded by the Cardiovascular Research Review Committee in cooperation with the Baylor Heart and Vascular Institute, Dallas, Texas.

View full text